Blockchain Registration Transaction Record

Aclarion Advances Chronic Back Pain Tech with 2026 Clinical & Reimbursement Goals

Aclarion updates on Nociscan platform for chronic back pain, targeting 2026 clinical trial results & US insurance reimbursement to expand adoption of its AI-driven diagnostic technology.

Chronic low back pain is a leading cause of disability worldwide, often leading to invasive diagnostic procedures, ineffective treatments, and significant healthcare costs. Aclarion's Nociscan platform represents a potential paradigm shift by offering a noninvasive, data-driven method to precisely locate the source of discogenic pain. This matters because accurate diagnosis is the critical first step toward effective, targeted interventions—potentially reducing unnecessary surgeries, improving patient outcomes, and lowering the overall economic burden of chronic pain management. Progress in payer reimbursement is crucial for patient access, making Aclarion's efforts to secure insurance coverage a direct indicator of the technology's move from innovation to practical, scalable clinical utility.